Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishnan Bhaskaran

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
The Lancet. Diabetes & Endocrinology|May 1, 2021
New insights into the association between body-mass index and severe COVID-19Krishnan Bhaskaran
International Journal of Epidemiology|April 8, 2014
What is the difference between missing completely at random and missing at random?Krishnan Bhaskaran, Liam Smeeth
The Lancet. Infectious Diseases|May 24, 2014
Fighting influenza--a new weapon in the armoury?Krishnan Bhaskaran, Sara L Thomas
JAMA|July 2, 2016
Prenatal Vitamin D and Offspring WheezingKrishnan Bhaskaran, Liam Smeeth, Stephen Evans
BMJ Open|August 22, 2020
What are the implications of using individual and combined sources of routinely collected data to identify and characterise incident site-specific cancers? a concordance and validation study using linked English electronic health records dataHelen Strongman, Rachael Williams, Krishnan Bhaskaran
Heart (British Cardiac Society)|December 15, 2010
Cardiovascular consequences of air pollution: what are the mechanisms?Krishnan Bhaskaran, Paul Wilkinson, Liam Smeeth
BMC Medical Research Methodology|March 30, 2022
Immortal time bias for life-long conditions in retrospective observational studies using electronic health recordsFreya Tyrer, Krishnan Bhaskaran, Mark J Rutherford
European Urology|July 31, 2013
Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.: beta-blockers and prostate cancer survival--interpretation of competing risks modelsKrishnan Bhaskaran, Bernard Rachet, Stephen Evans, et al.
British Journal of Cancer|February 28, 2019
Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individualsHelen Strongman, Adam Brown, Liam Smeeth, et al.
BMJ Open|October 3, 2022
COVID-19 during pregnancy and risk of pregnancy loss (miscarriage or stillbirth): a systematic review protocolJennifer Campbell, Rachael Williams, Mia Harley, et al.
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
The Lancet. Diabetes & Endocrinology|May 1, 2021
New insights into the association between body-mass index and severe COVID-19Krishnan Bhaskaran
International Journal of Epidemiology|April 8, 2014
What is the difference between missing completely at random and missing at random?Krishnan Bhaskaran, Liam Smeeth
The Lancet. Infectious Diseases|May 24, 2014
Fighting influenza--a new weapon in the armoury?Krishnan Bhaskaran, Sara L Thomas
JAMA|July 2, 2016
Prenatal Vitamin D and Offspring WheezingKrishnan Bhaskaran, Liam Smeeth, Stephen Evans
BMJ Open|August 22, 2020
What are the implications of using individual and combined sources of routinely collected data to identify and characterise incident site-specific cancers? a concordance and validation study using linked English electronic health records dataHelen Strongman, Rachael Williams, Krishnan Bhaskaran
Heart (British Cardiac Society)|December 15, 2010
Cardiovascular consequences of air pollution: what are the mechanisms?Krishnan Bhaskaran, Paul Wilkinson, Liam Smeeth
BMC Medical Research Methodology|March 30, 2022
Immortal time bias for life-long conditions in retrospective observational studies using electronic health recordsFreya Tyrer, Krishnan Bhaskaran, Mark J Rutherford
European Urology|July 31, 2013
Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.: beta-blockers and prostate cancer survival--interpretation of competing risks modelsKrishnan Bhaskaran, Bernard Rachet, Stephen Evans, et al.
British Journal of Cancer|February 28, 2019
Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individualsHelen Strongman, Adam Brown, Liam Smeeth, et al.
BMJ Open|October 3, 2022
COVID-19 during pregnancy and risk of pregnancy loss (miscarriage or stillbirth): a systematic review protocolJennifer Campbell, Rachael Williams, Mia Harley, et al.
Pageof 20